Skip to main content
SpringerLink
Log in

Second Trimester Medical Termination of Pregnancy with Combined Intracervical and Intravaginal Misoprostol: Comparative Analysis with Intravaginal Misoprostol—A Pilot Study

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Context

Intravaginal placement of misoprostol has been used extensively to terminate second trimester pregnancies. Intracervical misoprostol is an alternative method of termination of pregnancy for women in this period of gestation.

Objective

To assess the efficacy and safety of combined intracervical and intravaginal misoprostol in the management of mid-trimester medical termination of pregnancy and to compare it with intravaginal misoprostol.

Materials and Methods

In this IRB approved prospective study, twenty-two women (mean age 25.4 ± 3.2 years, range 23–32 years; mean BMI 22.3 ± 3.4 kg/m2; mean parity 2.1 ± 1.4, average gestational age 17.9 ± 2.4 weeks) underwent second trimester termination of pregnancy at our institution. Patient cohort was randomized into two treatment protocols depending on the drug used and route of administration. Induction-abortion interval, need for surgical evacuation, completeness of abortion and side effects if any were documented.

Results

Mean induction-abortion interval for intravaginal group and combination group was comparable (t = 7.9 ± 1.8 and 6.5 ± 3.5 h, respectively). Three patients required surgical evacuation for incomplete abortion (n = 2 after vaginal misoprostol and one after intracervical–intravaginal misoprostol). Number of patients aborting within 6 h was more in the intracervical–intravaginal group (36.3 %). Patients with intracervical misoprostol complained of abdominal pain more often than those in other groups. Excessive bleeding and uterine rupture was not seen in any patient.

Conclusion

Intracervical misoprostol is an effective method of medical treatment of second trimester pregnancy failure. Its short induction to abortion interval and acceptable safety profile makes induction via the cervical route acceptable for second trimester abortion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Berghella V, Airoldi J, O’Neill AM, et al. Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review. BJOG. 2009;116:1151.

    Article  CAS  PubMed  Google Scholar 

  2. Kapp N, Borgatta L, Stubblefield P, et al. Mifepristone in second-trimester medical abortion. Obstet Gynecol. 2007;110:1304.

    Article  CAS  PubMed  Google Scholar 

  3. Ramsey PS, Savage K, Lincoln T, et al. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Obstet Gynecol. 2004;104:138.

    Article  CAS  PubMed  Google Scholar 

  4. Webster D, Penney GC, Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol. 1996;103:706–9.

    Article  CAS  PubMed  Google Scholar 

  5. Ashok PW, Templeton A, Wagaarachchi PT, et al. Mid trimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004;69(1):51–8.

    Article  CAS  PubMed  Google Scholar 

  6. Rouzi AA, Almansouri N, Sahly N, et al. Efficacy of intra-cervical misoprostol in the management of early pregnancy failure. Sci Rep. 2014;4:7182.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ghorab MN, El Helw BA, Nabil M. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol: a comparative study. Acta Obstet Gynecol Scand. 1998;77(4):429–32.

    Article  CAS  PubMed  Google Scholar 

  8. Paz B, Ohel G, Tal T, et al. Second trimester abortion by laminaria followed by vaginal misoprostol or intrauterine prostaglandin F2alpha: a randomized trial. Contraception. 2002;65(6):411–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Padmashree Dr DY Patil Hospital, Navi Mumbai, India

    Gaurav Shyam Desai, Abhishek Chandavarkar (Lecturer), Sriram Gopal (Professor), Ganpat Sawant (Professor) & Shyam V. Desai (Professor)

Authors
  1. Gaurav Shyam Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhishek Chandavarkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sriram Gopal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ganpat Sawant
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shyam V. Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaurav Shyam Desai.

Ethics declarations

Conflict of interests

All authors have no conflict of interest.

Ethical Standards

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5).

Informed Consent

Informed consent was obtained from all patients for being included in the study.

Additional information

Gaurav S Desai, Registrar; Abhishek Chandavarkar, Lecturer; Sriram Gopal, Professor; Ganpat Sawant, Professor; Shyam V Desai, Professor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desai, G.S., Chandavarkar, A., Gopal, S. et al. Second Trimester Medical Termination of Pregnancy with Combined Intracervical and Intravaginal Misoprostol: Comparative Analysis with Intravaginal Misoprostol—A Pilot Study. J Obstet Gynecol India 66 (Suppl 1), 157–160 (2016). https://doi.org/10.1007/s13224-015-0827-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-015-0827-1

Keywords

Search

Navigation